All lobbying filings

CAPITOL COUNSEL LLC

Lobbying for CMC PHARMACEUTICALS · Developing new and better drug formulations.

Filing Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Income

$40,000.00

What the client paid this registrant for the period.

Client based in

Ohio

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Budget/Appropriations

Support for Department of Defense Chemical Biological Defense medical countermeasures pre and post-exposure protection funding.

Defense

Issues related to the FY26 National Defense Authorization Act and Defense Appropriations.

Government Issues

Support for Department of Defense Chemical Biological Defense medical countermeasures pre and post-exposure protection policy.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.